Status: current, Defined. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4545627011 | Cabotegravir 200 mg/mL prolonged-release suspension for injection | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 4571949018 | Product containing precisely cabotegravir 200 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Is a | Cabotegravir only product in parenteral dose form | true | Inferred relationship | Some | ||
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Has manufactured dose form | Extended-release suspension for injection | true | Inferred relationship | Some | ||
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Has precise active ingredient | Cabotegravir | true | Inferred relationship | Some | 1 | |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Has BoSS | Cabotegravir | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR